Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 10 July 2008, doi:10.1136/bmj.a345
Cite this as: BMJ 2008;337:a345
Linus Johnsson, student1, Mats G Hansson, professor1, Stefan Eriksson, senior researcher1, Gert Helgesson, senior researcher2
1 Centre for Research Ethics and Bioethics, Uppsala University, Uppsala Science Park, SE-751 85 Uppsala, Sweden, 2 Unit for Bioethics, LIME, Karolinska Institutet, Berzelius väg 3, SE-171 77 Stockholm
Correspondence to: L Johnsson linus.johnsson{at}crb.uu.se
Design Cross sectional study of register data.
Setting Biobanks used in Swedish health care, 2005-6.
Population Data on refusal to consent were obtained for 1.4 million biobank samples per year from 20 of 21 counties.
Main outcome measures Rates of preliminary refusal to consent, confirmed refusal, and withdrawal of consent.
Results Patients refused consent to either storage or use of their samples in about 1 in 690 cases; about 1 in 1600 confirmed their decision by completing a dissent form. Rather than having the samples destroyed, about 1 in 6200 patients wanted to restrict their use. Of those who had previously consented, about 1 in 19 000 withdrew their consent.
Conclusions Refusal to consent to biobank research in Sweden is rare, and the interests of individuals and research interests need not be at odds. The Swedish healthcare organisation is currently obliged to obtain either consent or refusal to each potential use of each sample taken, and lack of consent to research is used as the default position. A system of presumed consent with straightforward opt out would correspond with peoples attitudes, as expressed in their actions, towards biobank research.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses